Biocompatibility / Safety
All appropriate biocompatibility tests have been performed. Biocompatibility of HYABELL® has been assessed according to the ISO10993: 2009 standards and encompassed all tests.
In addition to the international standard tests, further longer intracutaneous reactivity evaluation has been performed with HYABELL® Ultra (24 mg/ml). Results of 12-month implantation tests have demonstrated that HYABELL® has high tolerance and biocompatibility profile.
HYABELL® products with lidocaine are easy to apply, providing a comfortable and gentle injection experience according to patients' and doctors' assessments.
HYABELL® products contain 0.3% lidocaine. For doctors, it facilitates the efficacy of treatments in general.
For patients, it improves the comfort by reducing pain, enhancing patients' satisfaction during and after the treatment.
Tel: +49 (0) 2173 / 101 91 80
Fax: +49 (0) 2173 / 101 91 82
All texts, graphics, photos and videos on this website have their copyright by Adoderm GmbH.
No third-party use in print or any digital way (example, social media as in Youtube, Facebook etc. ) is allowed. Any misuse is forbidden and will be legally prosecuted. All international laws apply.